Zealthy Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.6/10
Best for: coaching bundled into the price rather than sold separately
Zealthy falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $286 a month for the medication, plus a required membership; its compounded tirzepatide, at $351 plus a required membership, is 30% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
medication only; a membership is required on top
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked October 2026
FDA has sent three warning letters to the company behind Zealthy, FitRX, LLC, and it faces federal litigation; read the warnings and cons before considering it. Zealthy sells compounded semaglutide and tirzepatide on an asynchronous telehealth model. Medication starts at $151 a month for semaglutide and $216 for tirzepatide when bought quarterly, on top of a $135 monthly membership.
Is Zealthy legit?
Zealthy is a real, operating US company, and the FDA has issued it 3 warning letters. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate Zealthy 5.6/10 overall.
Is there a Zealthy promo or coupon code?
Zealthy has no code to type in. The current offer: new patients get $96 off the first month, bringing it to $49 (then about $135/mo), applied automatically at signup. It applies at checkout on its own. Coupon sites advertising a "Zealthy promo code" are not a source we can vouch for.
See how Zealthy compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Zealthy
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Zealthy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $286/mo + membership
- What's included
- Consult · Shipping · Coaching
- Availability
- All 50 states
- FDA status
- 3 FDA warning letters (details below)
How Zealthy scores
Six columns, each one computed from something Zealthy has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.1/10$351/month is 30% above the $269 median for compounded tirzepatide across the sellers we compare. Every listed price requires paying for several months up front. That figure is the medication only; a membership is required on top, so the comparison flatters it.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
2.0/10The FDA has issued it 3 warning letters. No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
5.5/10The price covers clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Zealthy
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Zealthy
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Zealthy involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Zealthy shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Zealthy which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $286, tirzepatide $351. That leaves out membership fees, first-month rates and insurance copays.
- Zealthy serves all 50 states.
- The FDA has issued Zealthy 3 warning letters. They are covered in the enforcement section below; read what they allege before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Zealthy
- Phone
- (877) 870-0323
- Zealthy offers email support
Cancelling Zealthy
Taken from the terms Zealthy publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly membership that renews automatically; quarterly, semi-annual and annual memberships are also sold
- Refund policy
- Medication, consultation and membership charges are non-refundable
Medications Zealthy lists
Zealthy lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
"as low as $151/month" for semaglutide "when purchased quarterly", plus the $135/month membership. The single-month medication price is not published.
"as low as $216/month" for tirzepatide, a 3-month-supply price, plus the $135/month membership. The single-month medication price is not published.
Check the price yourself before you pay
Every figure here comes from Zealthy's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price includes clinician visits, shipping and coaching
- Serves all 50 states
Against it
- Semaglutide costs $286 a month for the medication, plus a required membership, 44% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $351 a month for the medication, plus a required membership, 30% above the $269 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Zealthy 3 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Zealthy charges
The standing price at Zealthy is $286/month for the medication, plus a required membership.
- Compounded semaglutide: $286/month + membership
- Compounded tirzepatide: $351/month + membership
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Zealthy's $351 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Some of Zealthy's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.
What Zealthy dispenses
Zealthy prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Zealthy tells you that it treats patients in all 50 states. It also offers coaching as part of the plan. The FDA has issued Zealthy 3 warning letters, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Zealthy will not tell you, treat that as a warning sign. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Zealthy bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- you want coaching bundled in rather than billed on top
- you need access wherever you live
Our read
Zealthy costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why Zealthy scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. MangoRx is the nearest comparison we review, and worth reading alongside this. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
Zealthy falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $286 a month for the medication, plus a required membership; its compounded tirzepatide, at $351 plus a required membership, is 30% above the $269 median among the sellers we compare.
Before you pay Zealthy
Starting at $286 a month for the medication, plus a required membership. Check today's price, then start the intake.
Where Zealthy is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
If none of these fits, our guide to alternatives to Zealthy sets more sellers in the same category beside Zealthy on price, states and what the price includes.
Compare Zealthy head to head
Our head-to-head pages for Zealthy are Zealthy vs TrimRx, Zealthy vs Remedy Meds, Zealthy vs Henry Meds, Zealthy vs Hers, Zealthy vs Ivy Rx, and Zealthy vs Nurx.
Frequently Asked Questions
How to check Zealthy yourself
- How to Get a GLP-1 Prescription
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Connecticut, Delaware, Idaho, Michigan, Montana, New Mexico, Pennsylvania, West Virginia and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Zealthy has an FDA warning letter on record, dated September 9, 2025
This letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this Zealthy review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Zealthy's current pricing
Plans start at $286 a month for the medication, plus a required membership. Whether you qualify is a clinician's decision, made after your intake.